June 12 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES
QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS
QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES
QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026
Source text: ID:nBw4Lyg3Wa
Further company coverage: QNCX.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.